View Latest Medical and Pharma Bids and Tenders

Supply of Annual Requirements-Bacteriology (Chemicals,Reagents,Media,,Glassware, Laboratory Consumables,& Laboratory Equipment)

Supply of Quality Assurance of Animal origin feed for Food safty & Export Facilitations (Chemicals,Reagents,Media,,Glassware, LaboratoryConsumables, & Laboratory Equipment)

Supply of Production of compatible & High Quality Animal vaccine Locally Substitution of vaccine import (Chemicals,Reagents, Media,,Glassware, Laboratory Consumables,Laboratory Equipment & pharmacy item)

Supply of FMD Vaccine Production Project (Chemicals,Reagents,Media, ,Glassware, Laboratory Consumables, Laboratory Equipment & pharmacy item)

Supply of Medicine and Medical / Surgical equipments : BD Vacutainer Plastic Plus Heparin Blood Collection\nTubes with Sodium Heparin (10ml draw voume) for\nHLA Laboratory etc .

Supply of Medicine and Medical / Surgical equipments : BD Vacutainer Plastic Plus Heparin Blood Collection\nTubes with Sodium Heparin (10ml draw voume) for\nHLA Laboratory etc .

Supply of Medicine and Medical / Surgical equipments : Pipettes & Laboratory items and\nconsumable miscellaneous laboratory\nitems etc .

Supply of Medicine and Medical / Surgical equipments : Consumables bottles & lids for\nlaboratory use, pipettors, Tips and\nmiscellaneous laboratory items etc .

Supply of Medicine and Medical / Surgical equipments : Tetanus Toxoid Adsorbed 0.5ml (single\ndose) Ampoule/vial\nAdsorbed Tetanus Vaccine BP single dose\n(0.5mL)\nOR\nTetanus Toxoid Adsorbed USP single dose\n(0.5mL)\nEach 0.5mL single dose ampoule/vial should\ncontain an estimated potency of not less than\n40 units of Tetanus Toxoid. The vaccine to\ncontain Tetanus Toxoid produced by the\ngrowth of Clostridum Tetani in the form of\nTetanus Formol Toxoid.\nNote:\n1. Offers should be only from vaccine suppliers\nrecommended by World Health Organization\nfor bulk purchase for U.N. Agencies (WHO pre-\nqualified).\n2. The following documents should be\nsubmitted pre- shipment for each lot of vaccine\ndispatched. (a)Invoice (b) Certificate of origin\n(c) Certificate of analysis (d)Lot release\ncertificate from National control\nLaboratory(NCL) from country of\norigin.(e)Summary lot protocols of production\nprocedure & quality control testing. These\ndocuments should be submitted pre-shipment\nto the National Control Laboratory for Vaccines\n(MRI) Sri Lanka.\n3. The product should be from fresh stocks and\neach consignment should be prepared\npreferably from a single batch.\n4. The product should have a minimum 2/3 of\nremaining shelf life at the time of delivery at\nMSD.\n5. The vaccine should also comply with the\ngeneral requirements for vaccines in the\nBP,USP or other pharmacopeial standards\napproved by NMRA, Sri Lanka.\n6. Cold Chain monitors or WHO recommended\nother cold chain monitoring device should be\nincluded for each carton and the cold chain etc .

Supply of Medicine and Medical / Surgical equipments : Bacillus Calmette-Guerin Vaccine (BCG) 20\ndose vial (with a suitable diluent)\nBacillus Calmette-Guerin vaccine (BCG) 20\ndose Vial\nBacillus Calmette-Guerin vaccine BP or USP\n(BCG Vaccine)\nEach infant (<1 year old) dose should contain\n0.025mg of live Bacillus Calmette - Guerin and\nwhen reconstituted, the dose should be 0.05mL\n1.Offers should be only from vaccine suppliers\nrecommended by World Health Organization\n(WHO) for bulk purchase for the UN Agencies.\n2. The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis, lot\nrelease certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production and\nquality control test data should be submitted for\nprotocol review.\n3. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. The vaccine should also comply with the\ngeneral requirements for vaccines in the BP or\nUSP.\n5. The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\n6. Vaccine should be stored at a temperature\nof 2'C-8'C. Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack during\ndelivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\n7. Each vial to be provided with a suitable\nsterile diluent.\n8. Each vial should contain a suitable vaccine\nvial monitor.\n9. Must be a WHO prequalified product. etc .